PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Clinician Training and Texts Fail to Raise Pediatric HPV Vaccination in Randomized Trial

human papillomavirus vaccineHPVadolescent immunizationtext message remindersclinician communication trainingcluster randomized trialvaccine uptakepediatricspreventive carepublic health Infectious Disease / Antimicrobials

Background Information

Text messages boost HPV vaccination rates in children.

Human papillomavirus (HPV) vaccination rates among adolescents remain below recommendations. Text messages to parents increased HPV vaccine initiation and completion, showing risk ratios of 1.17 and 1.29 respectively. Clinician communication training alone did not significantly impact vaccination rates; text messages were more effective. Text messages to parents can boost HPV vaccination rates in children.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Staras SAS, Bylund CL, Gurka MJ, Thompson LA, Hansen MD, Lin T, Wang P, Sanchez G, Chi X, Harle CA, DeGruccio K, Khalil GE, Shenkman EA

Citation: Staras SAS, Bylund CL, Gurka MJ, et al. Clinician Training, Text Messages, and Human Papillomavirus Vaccination Among Children Aged 10 to 12 Years: A Randomized Clinical Trial. JAMA network open. 2026;9(11):e2642247. doi:10.1001/jamanetworkopen.2026.42247

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.